Journal List > J Korean Foot Ankle Soc > v.20(3) > 1043388

Chun, Jeon, Choi, Kim, Nho, and Won: The Amputation Rate and Associated Risk Factors within 1 Year after the Diagnosis of Diabetic Foot Ulcer

Abstract

Purpose:

This study investigates the amputation rate within 1 year after the diagnosis of diabetic foot ulcer and its associated risk factors.

Materials and Methods:

This study enrolled 60 patients with diabetic foot ulcer. The mean and standard deviation age was 64.4±12.8 years (range, 32∼89 years); the mean and standard deviation prevalence period for diabetes mellitus was 21.0±7.5 years (range, 0.5∼36 years). The amputation rate was evaluated by dividing the subjects into two groups—the major and minor amputation groups—within 1 year following the initial diagnosis of diabetic foot ulcer. Multivariate Cox proportional hazards regression analysis was used to identify the risk factors for amputation.

Results:

The total amputation rate of 38.3% (n=23) was comprised of the amputation rate for the major amputation group (10.0%) and rate for the minor amputation group (23.8%). There was a high correlation between peripheral artery disease (toe brachial pressure index <0.7) and amputation (hazard ratio [HR] 5.81, confidence interval [CI] 2.09∼16.1, p<0.01). Nephropathy was significantly correlated with the amputation rate (HR 3.53, CI 1.29∼9.64, p=0.01).

Conclusion:

Clinicians who treat patients with diabetic foot complications must understand the fact that the amputation rate within 1 year is significant, and that the amputation rate of patients with peripheral artery disease or nephropathy is especially high.

Go to : Goto

REFERENCES

1.Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin North Am. 2013. 97:775–90.
crossref
2.Singh N., Armstrong DG., Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005. 293:217–28.
crossref
3.Stiegler H. Das diabetische Fußsyndrom [Diabetic foot syndrome]. Herz. 2004. 29:104–15. German.
4.Gregg EW., Sorlie P., Paulose-Ram R., Gu Q., Eberhardt MS., Wolz M, et al. Prevalence of lower-extremity disease in the US adult population >=42 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004. 27:1591–7.
5.Winkley K., Stahl D., Chalder T., Edmonds ME., Ismail K. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complications. 2007. 21:341–9.
crossref
6.Morbach S., Furchert H., Gröblinghoff U., Hoffmeier H., Kersten K., Klauke GT, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a de-cade. Diabetes Care. 2012. 35:2021–7.
crossref
7.Won SH., Chung CY., Park MS., Lee T., Sung KH., Lee SY, et al. Risk factors associated with amputation-free survival in patient with diabetic foot ulcers. Yonsei Med J. 2014. 55:1373–8.
crossref
8.Faglia E., Clerici G., Caminiti M., Curci V., Somalvico F. Prognostic difference between soft tissue abscess and osteomyelitis of the foot in patients with diabetes: data from a consecutive series of 452 hospitalized patients. J Foot Ankle Surg. 2012. 51:34–8.
crossref
9.Beks PJ., Mackaay AJ., de Neeling JN., de Vries H., Bouter LM., Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995. 38:86–96.
crossref
10.Høyer C., Sandermann J., Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg. 2013. 58:231–8.
crossref
11.Sharp CS., Bessman AN., Wagner FW Jr., Garland D. Microbiology of deep tissue in diabetic gangrene. Diabetes Care. 1978. 1:289–92.
crossref
12.Pscherer S., Dippel FW., Lauterbach S., Kostev K. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes. 2012. 6:241–6.
crossref
13.Miyajima S., Shirai A., Yamamoto S., Okada N., Matsushita T. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract. 2006. 71:272–9.
crossref
14.Kaminski M., Frescos N., Tucker S. Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on hae-modialysis. Intern Med J1. 2012. 42:e120–8.
crossref
Go to : Goto

jkfas-20-121f1.tif
Fig. 1.
Kaplan-Meier curves depending on toe-brachial pressure index (log-rank test p<0.01). TBPI: toe-brachial pressure index.
undefined
jkfas-20-121f2.tif
Fig. 2.
Kaplan-Meier curves depending on nephropathy (log-rank test p<0.01).
undefined
Table 1.
Demographic and Clinical Patient Characteristics
Characteristic Value
Mean age (yr) 64.4±12.8
Sex
Male 34 (56.7)
Female 26 (43.3)
Type of diabetes
Type 1 4 (6.7)
Type 2 56 (93.3)
Treatment
Insulin 29 (48.3)
Tablet 31 (51.7)
Current smoking status
Non- or ex-smoker 34 (56.7)
Smoker 26 (43.3)
Mean duration of diabetes (yr) 21.0±7.5
Mean glycosylated hemoglobin level (%) 7.3±1.2
Wagner classification
Grade 1 26 (43.3)
Grade 2 9 (15.0)
Grade 3 15 (25.0)
Grade 4 10 (16.7)
Grade 5 0
Duration of ulcer (mo) 4.1±2.3
ABPI
≥0.9 39 (65.0)
<0.9 21 (35.0)
TBPI
≥0.7 40 (66.7)
<0.7 20 (33.3)
Complication
Macrovascular 14 (23.3)
Microvascular 21 (35.0)
Nephropathy 24 (40.0)
Neuropathy 46 (76.7)
Cerebrovascular 10 (16.7)
Amputation
Major (above the ankle) 6 (10.0)
Minor (below the ankle) 17 (28.3)

Values are presented as mean±standard deviation or number (%). ABPI: ankle brachial pressure index, TBPI: toe-brachial pressure index.

Table 2.
Univariate Cox Proportional Hazards Regression Models
Explanatory variable All amputation (n=23) Major amputation (n=6) Minor amputation (n=17)
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Age 1.01 (0.98∼1.05) 0.31 1.05 (0.98∼1.12) 0.15 1.00 (0.97∼1.03) 0.87
Sex (male vs female) 1.67 (0.71∼3.89) 0.23 0.50 (0.16∼1.59) 0.24 1.98 (0.89∼4.44) 0.09
Duration of diabetes 1.03 (0.97∼1.09) 0.33 0.98 (0.93∼1.04) 0.5 0.99 (0.96∼1.02) 0.66
Smoking (current smoker) 1.07 (0.59∼1.97) 0.82 0.03 (0.00∼13.17) 0.28 1.29 (0.69∼2.42) 0.43
ABPI (<0.9) 5.83 (2.27∼14.9) <0.01 11.11 (1.29∼96.17) 0.02 4.79 (1.66∼13.8) <0.01
TBPI (<0.7) 7.64 (2.81∼20.7) <0.01 8.12 (0.96∼52.3) 0.05 5.03 (1.74∼14.5) <0.01
Severity of ulcer 4.12 (1.61∼10.5) <0.01 8.07 (0.94∼68.9) 0.05 3.35 (1.16∼9.65) 0.02
Duration of ulcer 1.18 (0.99∼1.40) 0.76 1.00 (0.93∼1.09) 0.89 0.99 (0.94∼1.05) 0.72
HbA1c (>7.5%) 1.06 (0.52∼2.14) 0.87 1.01 (0.32∼3.22) 0.99 0.50 (0.26∼0.95) 0.08
Macrovascular 2.04 (0.78∼5.32) 0.14 2.04 (0.55∼7.59) 0.29 1.10 (0.62∼1.97) 0.74
Microvascular 1.13 (0.46∼2.76) 0.77 0.91 (0.29∼2.89) 0.88 0.67 (0.36∼1.26) 0.22
Nephropathy 5.19 (1.99∼13.5) <0.01 10.03 (1.17∼86.5) 0.03 4.19 (1.41∼12.47) 0.01
Neuropathy 0.41 (0.14∼1.18) 0.10 24.8 (0.01∼81893.46) 0.44 1.13 (0.44∼2.89) 0.81
Cerebrovascular 1.53 (0.50∼4.60) 0.45 1.16 (0.31∼4.29) 0.83 0.60 (0.27∼1.36) 0.22

HR: hazard ratio, CI: confidence interval, ABPI: ankle brachial pressure index, TBPI: toe-brachial pressure index.

Table 3.
Multivariate Cox Proportional Hazards Regression Models
Explanatory variable All amputation (n=23) Major amputation (n=6) Minor amputation (n=17)
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
ABPI (<0.9) 1.46 (0.27∼7.78) 0.66 1.05 (0.06∼12.3) 0.65 2.02 (0.25∼16.6) 0.51
TBPI (<0.7) 5.81 (2.09∼16.1) <0.01 5.97 (1.52∼14.9) 0.02 4.07 (1.39∼11.9) 0.01
Severity of ulcer 0.72 (0.17∼2.99) 0.65 0.56 (0.08∼6.36) 0.73 0.84 (0.16∼4.36) 0.83
Nephropathy 3.53 (1.29∼9.64) 0.01 4.23 (1.04∼10.0) 0.04 3.23 (1.04∼10.0) 0.04

HR: hazard ratio, CI: confidence interval, ABPI: ankle brachial pressure index, TBPI: toe-brachial pressure index.

TOOLS
Similar articles